MORGAN LEETH: Open Payments
NPI 1720679640 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 96 payments from 17 companies in 2025. Trend: 2023 $109 · 2024 $1,048 · 2025 $1,787
Food & beverage: $1,787
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $295 |
| Ardelyx, Inc. | 13 | $246 |
| Madrigal Pharmaceuticals | 8 | $144 |
| QOL Medical, LLC | 5 | $123 |
| PFIZER INC. | 6 | $113 |
| GENZYME CORPORATION | 5 | $102 |
| Phathom Pharmaceuticals, Inc. | 5 | $99 |
| Lilly USA, LLC | 5 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $89 |
| Ipsen Biopharmaceuticals, Inc | 4 | $77 |
Products named: IBSRELA, RINVOQ, DUPIXENT, REZDIFFRA, Sucraid, VOQUEZNA, OMVOH, IQIRVO.
Industry payments across AL — which companies pay providers there.
